Significant Ownership of Commodore Capital LP

Signature - Title
Michael Kramarz - Managing Partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Commodore Capital LP.

Notify me when Commodore Capital LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Commodore Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ELVN Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share 9.9% $135M 6.02M Commodore Capital LP 30 Jun 2025
RLAY Relay Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $88.7M $19.1M 17M +27.3% Commodore Capital LP 30 Sep 2025
ASMB ASSEMBLY BIOSCIENCES, INC. Common Stock, par value $0.001 9.9% $29.3M 1.62M Commodore Capital LP 08 Aug 2025
SABS SAB BIOTHERAPEUTICS, INC. Common Stock, $0.0001 par value per share 9.9% $9.59M 4.52M Commodore Capital LP 26 Sep 2025
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 9.9% $5.62M 9.69M Commodore Capital LP 01 Oct 2025
ANRO Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share 9.8% $12.8M 3.19M Commodore Capital LP 20 Oct 2025
COGT Cogent Biosciences, Inc. Common Stock, $0.001 Par Value 7.2% $147M $54.6M 10.2M +59.3% Commodore Capital LP 30 Sep 2025
DRUG Bright Minds Biosciences Inc. Common Shares, without par value 7.2% $15.4M 500K COMMODORE CAPITAL LP 31 Dec 2024
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 6.5% $42.8M $7.89M 5.7M +22.6% Commodore Capital LP 30 Sep 2025
TYRA Tyra Biosciences, Inc. Common Stock, $0.0001 par value per share 6.3% $47.2M $8.74M 3.38M +22.7% Commodore Capital LP 30 Sep 2025
LB PHARMACEUTICALS INC Common Stock, $0.0001 par value per share 5.5% 1.23M Commodore Capital LP 11 Sep 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 5.1% $89.2M 5.65M Commodore Capital LP 10 Nov 2025
NRIX Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share 4.9% $34.9M -$646K 3.78M -1.82% Commodore Capital LP 30 Sep 2025
MRUS Merus N.V. Common Shares, (euro) 0.09 nominal value per share 4.7% $192M -$12.3M 3.53M -6% Commodore Capital LP 30 Jun 2025
CLDX Celldex Therapeutics, Inc. Common Stock, par value $.001 4.6% $78.3M -$8.32M 3.03M -9.6% Commodore Capital LP 30 Sep 2025
VRDN Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value 3.9% $69.1M -$23.7M 3.2M -25.6% Commodore Capital LP 30 Sep 2025
NGNE Neurogene Inc. Common Stock, $0.000001 par value 3% $9.17M 428K Commodore Capital LP 30 Jun 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 2.9% $12.1M 1.1M COMMODORE CAPITAL LP 31 Dec 2024
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 2% $56M -$56.5M 585K -50.2% Commodore Capital LP 30 Sep 2025
NKTX Nkarta, Inc. Common Stock, $0.0001 par value per share 0.5% $742K 352K COMMODORE CAPITAL LP 31 Dec 2024
CRDF Cardiff Oncology, Inc. Common Stock 0% $0 -$21.9M 0 -100% Commodore Capital LP 30 Jun 2025
SLDB Solid Biosciences Inc. Common Stock $0.001 par value per share 0% $0 -$31.6M 0 -100% Commodore Capital LP 30 Jun 2025

Schedules 13D/G Reported by Commodore Capital LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.